A Computational Approach to Determine the Potential Inhibition of the Gomesin Peptide as an AKT1 Inhibitor in Breast Cancer

Abstract

Animal trials and in vitro drug screening can improve drug discovery. However, such pre-clinical screenings are often costly and time-consuming. Due to this, a more effective technique is developed using in silico method for the same.